Cargando…
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
BACKGROUND: Uveitis associated with juvenile idiopathic arthritis is a cause of major ocular morbidity. A substantial proportion of children are refractory to systemic methotrexate and TNF inhibitors. Our aim was to study the safety and efficacy of tocilizumab in children with juvenile idiopathic ar...
Autores principales: | Ramanan, Athimalaipet V, Dick, Andrew D, Guly, Catherine, McKay, Andrew, Jones, Ashley P, Hardwick, Ben, Lee, Richard W J, Smyth, Matthew, Jaki, Thomas, Beresford, Michael W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134526/ https://www.ncbi.nlm.nih.gov/pubmed/32280950 http://dx.doi.org/10.1016/S2665-9913(20)30008-4 |
Ejemplares similares
-
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
por: Ramanan, Athimalaipet V., et al.
Publicado: (2018) -
Juvenile Idiopathic Arthritis Associated Uveitis
por: Carlsson, Emil, et al.
Publicado: (2021) -
Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy
por: Cann, Megan, et al.
Publicado: (2018) -
Juvenile idiopathic arthritis-associated uveitis
por: Clarke, Sarah L. N., et al.
Publicado: (2016) -
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
por: Ramanan, Athimalaipet V, et al.
Publicado: (2014)